Recent News

Look for us at Booth 1007

We are excited to announce that OSOD LLC will be participating in…

OSOD LLC is delighted to announce the addition of four distinguished members to our team of vision scientists. Each of these individuals possesses valuable…

Vision scientists at OSOD are utilizing customized stimuli and analysis techniques to advance understanding of drug effects on the visual system in a non-…

Vision scientists at OSOD enthusiastically announce the arrival of a powerful new tool that promises to enhance our understanding of ocular abnormalities in…

OSOD LLC is a leading provider of innovative solutions in ocular research, specializing in advanced techniques for ocular drug delivery. Our expertise includes…

We'll be in Denver for ARVO 2022.

OSOD will be in booth 2208.  We hope to see you there!

…

Dr. Rob Shimizu brings over 35 years of corporate experience in ophthalmology ranging from research to development of pharmaceuticals, ocular devices, and combination products…

OSOD now has the capability of performing non-invasive optical coherence tomography angiography with our Heidelberg Spectralis® instruments.  We are currently exploring the…

OSOD is proud to welcome Dr. Craig Cross and Dr. Chuck O'Neill to the OSOD Executive Board. They each bring vast experience and new perspectives that go toward moving the…

We are pleased to annouce the addition of Dr. Ala Moshiri, Assistant Professor of Vitreoretinal Surgery and Uveitis at the UC Davis School of Medicine, to the clinical and…

OSOD is pleased to annouce that Dr. Carl Marfurt, Professor of Anatomy and Cell Biology at the Indiana University School of Medicine, has joined our team of vision scientists…

We are thrilled to welcome Dr. Donald O. Mutti to the OSOD vision science team. Dr. Mutti is the E.F. Wildermuth Foundation Professor of Optometry at The Ohio State University…

I knew Hank well as a fellow vision scientist with a focus on cornea, and in recent years as an important member of our consulting group that interacts with industry. He was a…

The goal of this study was to characterize functional and anatomic sequelae of a bleb induced by subretinal injection. Subretinal injections (100 µl) of balance salt solution (…

Histological evaluation of Wistar rats after 3 or 6 month of intense cyclic light exposure. Comparable H&E stained sections of retina of control (A, D) rats vs. intense…

Chris Murphy, DVM, Ph.D., DAVCO, founder and CEO of Ocular Services on Demand (OSOD, LLC) and EyeKor, LLC, is the recipient of the 2015 career achievement award in ocular…

The ability of light to enact damage on the neurosensory retina and underlying structures has been well understood for hundreds of years. While the eye has adapted several…